Preparation, Characterization, and Pharmacokinetic Evaluation of Imperatorin Lipid Microspheres and Their Effect on the Proliferation of MDA-MB-231 Cells

Xin‐Li Liang, Xulong Chen, Guowei Zhao, Tao Tang, Wei Dong, Chunyan Wang, Jing Zhang, Zheng‐Gen LiaoPharmaceutics 2018 · DOI

TL;DR

This paper presents a method for preparing and optimizing imperatorin-loaded lipid microspheres using nanoemulsion technology and response surface methodology. These optimized microspheres demonstrate enhanced bioavailability and significantly improved inhibition of MDA-MB-231 breast cancer cell proliferation compared to imperatorin alone.

What Problem Does This Paper Address?

Imperatorin, a compound derived from traditional Chinese medicine, shows promising anticancer, anti-inflammatory, and other pharmacological activities. However, its poor water solubility and good lipid solubility limit its bioavailability and make it challenging to formulate for effective drug delivery, particularly for intravenous administration. This study aims to overcome these limitations by developing and optimizing imperatorin-loaded lipid microspheres, a formulation strategy that can encapsulate lipophilic drugs and improve their delivery.

Methods

The researchers employed nanoemulsion technology to prepare imperatorin lipid microspheres. To optimize the formulation, they utilized Response Surface Methodology (RSM), specifically a Central Composite Design (CCD). This statistical approach allowed them to efficiently explore the complex relationships between formulation variables (egg lecithin, poloxamer 188, and soybean oil) and key response parameters (particle size, polydispersity index, zeta potential, drug loading, and encapsulation efficiency). They used Design-Expert 8.06 software to analyze the data and generate three-dimensional response surface graphs to identify optimal conditions. Characterization of the microspheres involved Scanning Electron Microscopy (SEM) for morphology, laser particle size analysis for size and PDI, and zeta potential measurements. Pharmacokinetic studies in rats were conducted using a validated High-Performance Liquid Chromatography (HPLC) method. The anti-proliferative effect on MDA-MB-231 cells was assessed using the MTT assay.

Datasets

Not discussed in the paper. The study focuses on the formulation and characterization of imperatorin lipid microspheres and their biological evaluation.

Key Insights and Ideas

  • Lipid microspheres as a viable delivery system for lipophilic drugs: The study successfully demonstrates that lipid microspheres can effectively encapsulate imperatorin, a lipophilic compound with poor water solubility, thereby improving its delivery potential.
  • RSM-CCD for efficient formulation optimization: The use of response surface methodology with a central composite design proved to be a powerful tool for optimizing the complex formulation of lipid microspheres, requiring fewer experiments than traditional methods while providing high accuracy.
  • Enhanced bioavailability and anti-cancer efficacy: The optimized imperatorin lipid microspheres significantly increased imperatorin's bioavailability in rats and showed a superior inhibitory effect on MDA-MB-231 breast cancer cell proliferation compared to imperatorin administered alone.
  • Trade-off between bioavailability and half-life: While the microspheres improved bioavailability and Cmax, they also resulted in a shorter half-life, suggesting a need for further research into prolonging their duration of action.

Key Results

  • Optimal Formulation: The optimized formulation consisted of 1.39 g of egg lecithin, 0.21 g of poloxamer 188, and 10.57% soybean oil.
  • Microsphere Characteristics: The optimized imperatorin lipid microspheres exhibited a particle size of 168 ± 0.54 nm, a polydispersity index (PDI) of 0.138 ± 0.02, and zeta potentials of -43.5 ± 0.5 mV.
  • Drug Loading and Encapsulation: Drug loading was 0.833 ± 0.27 mg/mL, and encapsulation efficiency reached 90 ± 1.27%.
  • Pharmacokinetics: Intravenous administration of imperatorin lipid microspheres resulted in a significantly increased AUC(0-t) and Cmax compared to oral administration of imperatorin. However, the half-life was shorter (1.00 ± 0.40 h) for the microspheres compared to oral imperatorin (4.02 ± 1.09 h).
  • Anti-cancer Activity: Imperatorin lipid microspheres demonstrated a stronger inhibitory effect on MDA-MB-231 cell proliferation than imperatorin alone, with the inhibition rate increasing with concentration and culture time.

Limitations and Future Work

The authors acknowledge that the pharmacokinetic study revealed a short half-life for imperatorin delivered via lipid microspheres. This suggests that while the microspheres enhance bioavailability, their duration of action in vivo is limited. Future work should focus on strategies to increase the half-life and improve the residence time of imperatorin lipid microspheres in the bloodstream. This could involve exploring different formulation modifications or drug release mechanisms. Additionally, further in-depth studies on the mechanism of action and potential toxicity of these optimized microspheres would be beneficial.

Summary updated

Abstract

Imperatorin is a chemical compound belonging to the linear furanocoumarins. Imperatorin is attracting considerable attention because of its antitumor, antibacterial, anti-inflammatory, and anticoagulant activities, inhibition of myocardial hypertrophy, and other pharmacological efficacies. However, imperatorin has limited water solubility and has better lipid solubility; thus, we decided to design and synthesize imperatorin lipid microspheres to optimize the preparation conditions. The aim was to develop and formulate imperatorin lipid microspheres through nanoemulsion technology and apply the response surface⁻central composite design to optimize the imperatorin lipid microsphere formulation. The influence of the amounts of egg lecithin, poloxamer 188, and soybean oil for injection on the total percentage of the oil phase was investigated. The integrated effect of dependent variables, including particle size, polydispersity index, zeta potentials, drug loading, and encapsulation efficiency, was investigated. Data of overall desirabilities were fitted to a second-order polynomial equation, through which three-dimensional response surface graphs were described. Optimum experimental conditions were calculated by Design-Expert 8.06. Results indicated that the optimum preparation conditions were as follows: 1.39 g of egg lecithin, 0.21 g of poloxamer 188, and 10.57% soybean oil for injection. Preparation of imperatorin lipid microspheres according to the optimum experimental conditions resulted in an overall desirability of 0.7286, with the particle size of 168 ± 0.54 nm, polydispersity index (PDI) of 0.138 ± 0.02, zeta potentials of -43.5 ± 0.5 mV, drug loading of 0.833 ± 0.27 mg·mL<sup>-1</sup>, and encapsulation efficiency of 90 ± 1.27%. The difference between the observed and predicted values of the overall desirability of the optimum formulation was in the range from 2.4% to 4.3%. Subsequently, scanning electron microscopy was used to observe the micromorphology of the imperatorin lipid microspheres, showing round globules of relatively uniform shape and sizes within 200 nm. The effect of imperatorin lipid microspheres on MDA-MB-231 proliferation was investigated by the MTT method. Furthermore, pharmacokinetics in Sprague-Dawley rats was evaluated using orbital bleeding. A sensitive and reliable liquid chromatography with the high-performance liquid chromatography (HPLC) method was established and validated for the quantification of imperatorin in rat plasma samples. The data were calculated by DAS (drug and statistics) Pharmacokinetic Software version 3.3.0 (Version 3.3.0, Shanghai, China). Results demonstrated that imperatorin lipid microspheres can significantly enhance the bioavailability of imperatorin and can significantly inhibit MDA-MB-231 cell proliferation. In conclusion, our results suggested that the response surface⁻central composite design is suitable for achieving an optimized lipid microsphere formulation. Imperatorin lipid microspheres can improve the bioavailability of imperatorin and better inhibit the proliferation of MDA-MB-231 cells as compared to imperatorin alone.
BibTeX
@inproceedings{liang2018preparation,
  author = {Xin‐Li Liang and Xulong Chen and Guowei Zhao and Tao Tang and Wei Dong and Chunyan Wang and Jing Zhang and Zheng‐Gen Liao},
  title = {{Preparation, Characterization, and Pharmacokinetic Evaluation of Imperatorin Lipid Microspheres and Their Effect on the Proliferation of MDA-MB-231 Cells}},
  booktitle = {Pharmaceutics},
  year = {2018},
  doi = {10.3390/pharmaceutics10040236},
}
Figure